Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityActive in the last 2 years

Jilong Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0091-0333; OpenAlex author ID A5100660342. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

  1. Nano-enabled regulation of DNA damage in tumor cells to enhance neoantigen-based pancreatic cancer immunotherapy. Co-author DOI 10.1016/j.biomaterials.2024.122710↗
  2. Activated Natural Killer Cells-Dependent Dendritic Cells Recruitment and Maturation by Responsive Nanogels for Targeting Pancreatic Cancer Immunotherapy. Co-author DOI 10.1002/smll.202203114↗
  3. Co-inhibition of the TGF-β pathway and the PD-L1 checkpoint by pH-responsive clustered nanoparticles for pancreatic cancer microenvironment regulation and anti… Co-author DOI 10.1039/d0bm00916d↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junjie Deng · 2 shared papers, 2022–2024 · strength 0.35
  2. Yongheng Bai · 1 shared paper, 2024 · strength 0.19
  3. Jianxin Lyu · 1 shared paper, 2022 · strength 0.16
  4. Zhen Wang · 1 shared paper, 2022 · strength 0.16
  5. Jun Wang · 1 shared paper, 2020 · strength 0.11
  6. Yang Wang · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.